Company intelligence / Profile preview

Cady Dermatopharmacology

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Cady Dermatopharmacology is a biotechnology company focused on the development of innovative topical therapies for chronic inflammatory skin conditions. The company leverages its expertise in dermatopharmacology to design small molecule treatments aimed at addressing unmet needs in diseases such as psoriasis, atopic dermatitis, and acne. By focusing on localized delivery systems, Cady Dermatopharmacology seeks to maximize therapeutic efficacy while minimizing systemic side effects. The firm is currently advancing its early-stage pipeline through pre-clinical validation and formulation optimization.

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Cady Dermatopharmacology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cady Dermatopharmacology.

Explore the full profile